How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines? - Laverty, H G; Benson, C; Cartwright, E J; Cross, M J; Garland, C; Hammond, T; Holloway, C; McMahon, N; Milligan, J; Park, B K; Primohamed, M; Pollard, C; Radford, J; Roome, N; Sager, P; Singh, S; Suter, T; Suter, W; Trafford, A; Volders, P GA; Wallis, R; Weaver, R; York, M; Valentin, J P (Br J Pharmacol, 2011)